KEEP BUT DO NOT DISPLAY

Obesity Accounts for Greatest Jump in Healthcare Costs: 

New Link between Elevated Insulin and Breast Cancer Risk: 

Diabetes Causes Skin Problems

The European Commission has approved Novo’s Liraglutide (Victoza), for the treatment of Type 2 Diabetes in Adults.

As the economy slumped, waistlines surged, according to the latest national obesity report card, which found that adult obesity rates increased in 23 states over the past year. At the same time, not a single state posted a decrease in obesity, and three out of every ten children living in …

Diabetic Retinopathy on the Rise: After two decades on the rise, retinopathy now affects more than a third of all diabetes patients, according to the latest nationally representative estimate.

CRP Not Direct Cause of Heart Disease

Medtronic Diabetes is voluntarily recalling Quick-set® infusion sets that have lot numbers starting with the number “8”. These infusion sets are used with MiniMed Paradigm® Insulin Pumps. The action was taken because of a situation related to the tubing connector which may not allow the insulin pump to vent properly. …

POSSIBLE LINK BETWEEN INSULIN GLARGINE AND CANCER QUESTIONED –  MORE RESEARCH REQUIRED Experts stress patients should not stop using insulin and consult their doctor if concerned.  See This Week’s Item 1 Takeda’s Diabetes Drug Alogliptin Rejected by FDA  Asia’s biggest drugmaker, Takeda, failed to gain U.S. regulatory approval to market …

Another “not new” drug, but new combination added to the arsenal for treating diabetes. Takeda Pharmaceutical have announced that the FDA approved an extended-release version of the combination medication ACTOplus met(R) (pioglitazone HCl and metformin HCl) as an adjunct to diet and exercise for the treatment of Type 2 diabetes. …